Recruiting NCT07488013
The Impact of Early Regular Diet vs Conventional Clear Fluids Regimen on Colorectal Anastomosis
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: regular diet, Clear fluids.
- Who it may be relevant to
- Registry conditions: Colorectal Anastomosis. Basic parameters: 18 years — 60 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The goal of this clinical trial is to compare the effect of early regular feeding protocol vs conventional clear fluids regimen as per ERAS protocols in patients undergoing colorectal anastomosis. The main questions it aims to answer are: 1. Food tolerance and return of normal bowel Habbits. 2. Rate of Anastomotic leakage 3. Length of hospital stay
Interventions
- Behavioral regular diet
Regular diet will be initiated within the first 12 hours post-operatively - Behavioral Clear fluids
Clear fluids will be initiated post-operatively and then gradually updated to regular diet as the patient regains his normal motions
Primary outcome measures
- Duration of post-operative ileus [Time frame: from the beginning of the post-operative period up to 30 days]
- Rate of anastomotic leakage [Time frame: from the beginning of the post-operative period up to 30 days]
Secondary outcome measures (1)
- Length of hospital stay [Time frame: up to 4 weeks]
Eligibility criteria
Inclusion criteria
- Patients with a single, primary large bowel anastomosis
Exclusion criteria
- Patients with large bowel anastomosis and proximal diversion.
- Patients with severe systemic illnesses or comorbidities that may impact surgical outcomes or dietary tolerance (e.g., severe heart failure, renal failure, liver failure).
- Patients who require post-operative intensive care unit (ICU) admission or mechanical ventilation
- Patients with pre-existing conditions that may affect gastrointestinal function or nutrient absorption (e.g., Crohn's disease, malabsorption syndromes).
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- Kasr Alainy — Cairo
Identifiers
NCT: NCT07488013 · MD-148-2025